Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Scotte

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Revue Des Maladies Respiratoires|November 26, 2008
[NSCLC of early stage. The place of surgery]M Riquet, F Scotte
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer PatientsF Scotte, N Martelli, A Vainchtock, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 27, 2016
Basi cervical inflammatory massH Benkhatar, F Scotte, O Laccourreye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2021
Essential digital healthF Scotte, O Mir, M Di Palma, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2006
[Postoperative risk after induction treatment on surgery in non-small cell lung cancer]F Scotte, E Fabre-Guillevin, A Dujon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 23, 2023
Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic reviewA Molassiotis, I Y Zhao, M Crichton, et al.
Bulletin Du Cancer|April 27, 2010
[Angiogenesis inhibition: review of the activity of sorafenib, sunitinib and bevacizumab]E Barrascout, J Medioni, F Scotte, et al.
ESMO Open|September 18, 2025
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug developmentS Champiat, K Ouali, A Laparra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patientsS Oudard, E Banu, F Scotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2013
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumoursJ Cros, E Sbidian, S Hans, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Revue Des Maladies Respiratoires|November 26, 2008
[NSCLC of early stage. The place of surgery]M Riquet, F Scotte
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer PatientsF Scotte, N Martelli, A Vainchtock, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 27, 2016
Basi cervical inflammatory massH Benkhatar, F Scotte, O Laccourreye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2021
Essential digital healthF Scotte, O Mir, M Di Palma, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2006
[Postoperative risk after induction treatment on surgery in non-small cell lung cancer]F Scotte, E Fabre-Guillevin, A Dujon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 23, 2023
Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic reviewA Molassiotis, I Y Zhao, M Crichton, et al.
Bulletin Du Cancer|April 27, 2010
[Angiogenesis inhibition: review of the activity of sorafenib, sunitinib and bevacizumab]E Barrascout, J Medioni, F Scotte, et al.
ESMO Open|September 18, 2025
From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug developmentS Champiat, K Ouali, A Laparra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patientsS Oudard, E Banu, F Scotte, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 13, 2013
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumoursJ Cros, E Sbidian, S Hans, et al.
Pageof 2